Join our email list to stay up to date on the latest Amyloidosis news.
Sunday, January 21 | 8-11:30 AM ET | Via Zoom
Creating consensus around the research priorities primed to increase the pace and efficiency of amyloidosis research that will most improve the lives of those with amyloidosis.
ARC has gathered global experts from academic, clinical, regulatory, health policy, and other key areas to create consensus around the unmet needs within amyloidosis and identify the research initiatives needed to ultimately improve patient outcomes. The key areas of focus include basic and translational research, clinical research, and overall clinical care within AL and ATTR amyloidosis.